The FAM177A1 Research Fund has partnered with Perlara, PBC to
accelerate research and develop patient-focused treatments.
Click links below to read the FAM177A1 Cure Odyssey and a fascinating piece about how Perlara leveraged ChatGPT technology to learn more about FAM177A1 and how technology can be used to help all rare diseases.
"Imagine a collection of AI bots that empower the Jills and FAM177A1 Research Foundations of the world both operationally and scientifically — collectively, CureGPT. Like having your own Lt. Commander Data at your side on your Cure Odyssey!" ~Perlara